Showing results (211-220 of 333) with videos related to
Sort By:
Pageof 34
Blood Cancer Discovery|February 10, 2025
SOCS1 Protects Acute Myeloid Leukemia against Allogeneic T Cell-Mediated CytotoxicityEnoch Tin, Sergio Rutella, Ismat Khatri, et al.Blood Cancer Discovery|February 24, 2025
A Model of Intratumor and Interpatient Heterogeneity Explains Clinical Trials of Curative Combination Therapy for LymphomaAmy E Pomeroy, Adam C PalmerBlood Cancer Discovery|December 9, 2024
The Crossroads of Clonal Evolution, Differentiation Hierarchy, and Ontogeny in Leukemia DevelopmentChristopher M Sturgeon, Elvin Wagenblast, Franco Izzo, et al.Blood Cancer Discovery|November 27, 2024
New Approvals Advancing Blood Cancer MedicineBlood Cancer Discovery|August 6, 2024
Repurposing NAMPT Inhibitors for Germinal Center B Cell-Like Diffuse Large B-Cell LymphomaClaudio Scuoppo, Bowen Cai, Kenneth Ofori, et al.Blood Cancer Discovery|June 10, 2024
Mis-splicing of Mitotic Regulators Sensitizes SF3B1-Mutated Human HSCs to CHK1 InhibitionMartina Sarchi, Courtnee A Clough, Edie I Crosse, et al.Blood Cancer Discovery|November 2, 2023
Criteria for Diagnosis and Molecular Monitoring of NPM1-Mutated AMLBrunangelo Falini, Richard DillonBlood Cancer Discovery|November 20, 2023
Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7)Simone Filosto, Saran Vardhanabhuti, Miguel A Canales, et al.Blood Cancer Discovery|September 12, 2023
Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia TherapyChristopher A Eide, Stephen E Kurtz, Andy Kaempf, et al.Blood Cancer Discovery|September 1, 2023
MRD and Plasma Cell Dynamics after CAR T-cell Therapy in MyelomaOla Landgren, Dickran KazandjianPageof 34